IBDEI2EG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40712,0)
 ;;=L56.3^^159^1993^268
 ;;^UTILITY(U,$J,358.3,40712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40712,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,40712,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,40712,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,40713,0)
 ;;=L57.0^^159^1993^12
 ;;^UTILITY(U,$J,358.3,40713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40713,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,40713,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,40713,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,40714,0)
 ;;=L60.0^^159^1993^161
 ;;^UTILITY(U,$J,358.3,40714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40714,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,40714,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,40714,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,40715,0)
 ;;=L60.1^^159^1993^234
 ;;^UTILITY(U,$J,358.3,40715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40715,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,40715,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,40715,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,40716,0)
 ;;=L60.2^^159^1993^233
 ;;^UTILITY(U,$J,358.3,40716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40716,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,40716,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,40716,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,40717,0)
 ;;=L60.3^^159^1993^170
 ;;^UTILITY(U,$J,358.3,40717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40717,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,40717,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,40717,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,40718,0)
 ;;=L60.4^^159^1993^88
 ;;^UTILITY(U,$J,358.3,40718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40718,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,40718,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,40718,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,40719,0)
 ;;=L60.5^^159^1993^290
 ;;^UTILITY(U,$J,358.3,40719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40719,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,40719,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,40719,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,40720,0)
 ;;=L60.8^^159^1993^168
 ;;^UTILITY(U,$J,358.3,40720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40720,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,40720,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,40720,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,40721,0)
 ;;=L62.^^159^1993^169
 ;;^UTILITY(U,$J,358.3,40721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40721,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,40721,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,40721,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,40722,0)
 ;;=L64.9^^159^1993^33
 ;;^UTILITY(U,$J,358.3,40722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40722,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,40722,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,40722,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,40723,0)
 ;;=L65.9^^159^1993^231
 ;;^UTILITY(U,$J,358.3,40723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40723,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,40723,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,40723,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,40724,0)
 ;;=L70.0^^159^1993^6
 ;;^UTILITY(U,$J,358.3,40724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40724,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,40724,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,40724,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,40725,0)
 ;;=L70.1^^159^1993^1
 ;;^UTILITY(U,$J,358.3,40725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40725,1,3,0)
 ;;=3^Acne Conglobata
